The Discounted Cash Flow (DCF) valuation of Intra-Cellular Therapies Inc (ITCI) is (563.10) USD. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on DCF is -527.0%.
Based on the latest price of 131.87 USD and our DCF valuation, Intra-Cellular Therapies Inc (ITCI) is a sell. selling ITCI stocks now will result in a potential gain of 527.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (4,444.92) - (302.77) | (563.10) |
| Upside | -3470.7% - -329.6% | -527.0% |